NRX Pharmaceuticals, Inc. (NRXP)
2.29
+0.09
(+4.09%)
USD |
NASDAQ |
Apr 06, 10:25
NRX Pharmaceuticals Shareholders Equity (Quarterly) : -15.94M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Synergy CHC Corp. | -23.13M |
| Vivos Therapeutics, Inc. | 2.532M |
| Lantern Pharma, Inc. | 6.534M |
| IGC Pharma, Inc. | 7.423M |
| Vertex Pharmaceuticals, Inc. | 18.67B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.96M |
| Total Liabilities (Quarterly) | 28.89M |
| Debt to Equity Ratio | -0.0396 |
| Current Ratio | 0.3111 |
| Net Debt Paydown Yield | 1.40% |